Top Abstract Purchase Related
Home
>
Node
>
Subnode

Anti-hyperlipidemic agents

Kinoshita, M.

Nihon Rinsho. Japanese Journal of Clinical Medicine 60(5): 968-974

2002

ISSN/ISBN: 0047-1852
PMID: 12030001
Document Number: 543749
There are several drugs for hyperlipidemia except for statin and fibrate. Resin is a commonly used drug for hypercholesterolemia and is known to very useful for the prevention of coronary heart disease(CHD). Probucol is also used for hypercholesterolemia and recently is known that it prevent the restenosis of the coronary artery after PTCA. Nicotinic acid is used for hypertriglyceridemia and hypercholesterolemia, both. It is also known to very useful for the prevention of CHD. Eicosapentaenoic acid is effective for hypertriglyceridemia and also shows an inhibition of platelets aggregation. These drugs as well as statin and fibrate are used in combination with each other for severe hyperlipidemia.

Document emailed within 1 workday
Secure & encrypted payments

Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Krause, B.R. 2008: The development of novel anti-hyperlipidemic drugs: a tough business gets tougher Current Opinion in Investigational Drugs 9(9): 945-949
Takemoto, T.; Yanai, H. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 133-139
Fernández-Viadero, C.; Verduga, R.; Soto, J.; Alsar, M.J. 1993: The use of topical non-steroidal anti-inflammatory agents in elderly patients taking oral anticoagulation agents Medicina Clinica 100(5): 196-197
Lown, J.W. 1988: Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes Anti-Cancer Drug Design 3(1): 25-40
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Chimirri, A.; Grasso, S.; Montforte, A.M.; Monforte, P.; Zappalà, M. 1994: Anti-HIV agents. III. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]imidazo[4,5-b]pyridines Farmaco 49(5): 345-348
Chimirri, A.; Grasso, S.; Monforte, A.M.; Monforte, P.; Rao, A.; Zappalà, M.; Bruno, G.; Nicolò, F.; Scopelliti, R. 1997: Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2',3':4,5]imidazo[1,2-c]thiazoles Farmaco 52(11): 673-677
Tian, S.L.; Zhao, S.W.; Zhu, A.T.; Fang, Y.; Li, K.Q. 1993: Studies on anti-tumor agents. I: Synthesis and anti-cancer activity of amino acid derivatives of norcantharidin Yao Xue Xue Bao 28(11): 870-875
Materson, B.J.; Reda, D.J.; Cushman, W.C.; Henderson, W.G. 1995: Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents Journal of human hypertension 9(10): 791-796
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Pantazis, P.; Han, Z.; Balan, K.; Wang, Y.; Wyche, J.H. 2003: Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models Anticancer Research 23(5a): 3623-3638
Kawamura, H.; Nagano, H. 1987: Progress of therapeutic agents for asthma--1) Progress of anti-asthmatic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 45(8): 1830-1836
Weiss-Simon, C.; Spangenberg, G.; Michel, D. 1980: Anti-arrhythmic agents. 2. Special anti-arrhythmic effect, known drug interactions Fortschritte der Medizin 98(15): 569-572
Storozhuk, B.G. 1985: Anti-arrhythmia activity and side effects of various anti-arrhythmia agents Vrachebnoe Delo 3: 41-44
Grilliat, J.P.; Moneretvautrin, D.A.; You, B.; Reynier, A. 1984: Manifestations respiratoires et intolérance à l'aspirine et aux anti-inflammatoires non stéroïdiens - Respiratory manifestations and aspirin intolerance and non steroid anti-inflammatory agents Annales de Medecine Interne (Paris) 135(1): 21-25
Gatanaga, H. 2012: New anti-HIV agents Nihon Rinsho. Japanese Journal of Clinical Medicine 70(4): 655-659
Bracchi, G.; Vezzoli, F. 1976: Anti-arrhythmia agents La Clinica Terapeutica 78(1): 65-85
Kaufmann, G. 1974: Anti-arrhythmia agents Medizinische Klinik 69(18): 778-786